Advertisement
Screener

IMAX Corporation (IMAX) Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31)

IMAX Corporation Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31)

IMAX Corporation (IMAX) reported Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) of $3.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.

Discontinued › Income Statement › Other Income

us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCostOfSales · last filed 2019-02-26

  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2013-12-31 was $16.00M.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2013-09-30 was $3.10M, a 6.90% increase year-over-year.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2013-06-30 was $3.20M, a 10.34% increase year-over-year.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2013-03-31 was $5.50M, a 77.42% increase year-over-year.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2018 was $3.00M, a 23.08% decline from fiscal 2017.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2017 was $3.90M, a 42.65% decline from fiscal 2016.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2016 was $6.80M, a 26.88% decline from fiscal 2015.
  • IMAX Corporation equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2015 was $9.30M, a 57.63% increase from fiscal 2014.
Period endEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 3 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 6 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 9 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 12 month
2018-12-31$3.00M
10-K · filed 2019-02-26
2017-12-31$3.90M
10-K · filed 2019-02-26
2016-12-31$6.80M
10-K · filed 2018-02-27
2015-12-31$9.30M
10-K · filed 2017-02-23
2014-12-31$5.90M
10-K · filed 2016-02-24
2013-12-31$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19
$19.10M
derived: sum of 2 quarters · filed 2015-02-19
$22.30M
derived: sum of 3 quarters · filed 2015-02-19
$26.00M
10-K · filed 2015-02-19
2013-09-30$3.10M
10-Q · filed 2013-10-24
$6.30M
derived: sum of 2 quarters · filed 2013-10-24
$10.00M
10-Q · filed 2013-10-24
2013-06-30$3.20M
10-Q · filed 2013-07-25
$6.90M
10-Q · filed 2013-07-25
2013-03-31$5.50M
10-Q · filed 2013-04-25
2012-12-31$12.70M
10-K · filed 2014-02-20
2012-09-30$2.90M
10-Q · filed 2013-10-24
$5.80M
derived: sum of 2 quarters · filed 2013-10-24
$8.90M
10-Q · filed 2013-10-24
$12.20M
derived: sum of 4 quarters · filed 2013-10-24
2012-06-30$2.90M
10-Q · filed 2013-07-25
$6.00M
10-Q · filed 2013-07-25
$9.30M
derived: sum of 3 quarters · filed 2013-07-25
$12.00M
derived: sum of 4 quarters · filed 2013-07-25
2012-03-31$3.10M
10-Q · filed 2013-04-25
$6.40M
derived: sum of 2 quarters · filed 2013-04-25
$9.10M
derived: sum of 3 quarters · filed 2013-04-25
$11.50M
derived: sum of 4 quarters · filed 2013-04-25
2011-12-31$3.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
$6.00M
derived: sum of 2 quarters · filed 2013-02-21
$8.40M
derived: sum of 3 quarters · filed 2013-02-21
$9.80M
10-K · filed 2013-02-21
2011-09-30$2.70M
10-Q · filed 2012-10-25
$5.10M
derived: sum of 2 quarters · filed 2012-10-25
$6.50M
10-Q · filed 2012-10-25
$6.70M
derived: sum of 4 quarters · filed 2012-10-25
2011-06-30$2.40M
10-Q · filed 2012-07-26
$3.80M
10-Q · filed 2012-07-26
$4.00M
derived: sum of 3 quarters · filed 2012-07-26
$4.00M
derived: sum of 4 quarters · filed 2012-07-26
2011-03-31$1.40M
10-Q · filed 2012-04-27
$1.60M
derived: sum of 2 quarters · filed 2012-04-27
$1.60M
derived: sum of 3 quarters · filed 2012-04-27
$1.60M
derived: sum of 4 quarters · filed 2012-04-27
2010-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$200.00K
derived: sum of 2 quarters · filed 2012-02-24
$200.00K
derived: sum of 3 quarters · filed 2012-02-24
$200.00K
10-K · filed 2012-02-24
2010-09-30$0.00
10-Q · filed 2011-10-27
$0.00
derived: sum of 2 quarters · filed 2011-10-27
$0.00
10-Q · filed 2011-10-27
2010-06-30$0.00
10-Q · filed 2011-07-28
$0.00
10-Q · filed 2011-07-28
2009-12-31$0.00
10-K · filed 2012-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
EASTMAN KODAK CO (KODK)United States$0.931B-9.63
MOVING iMAGE TECHNOLOGIES INC. (MITQ)United States$0.006B-33.56